Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
CDC treats first monkeypox patient with SIGA's smallpox antiviral via expanded access
3 years ago
Pharma
Jazz Pharmaceuticals taps celebrity actor and epilepsy advocate to host YouTube ‘Care Giver’ series
3 years ago
Pharma
Marketing
State supreme court rules in favor of Eli Lilly in case over warning patients of risks when DTC ads are in play
3 years ago
Pharma
Law
FDA review spotlights risk of heart inflammation linked to Novavax's Covid vaccine — shares tumble
3 years ago
FDA+
Coronavirus
#ASCO22: Imbruvica keeps aggressive blood cancer at bay for 6+ years, but misses the mark in overall survival
3 years ago
R&D
Pharma
Bioethicists weigh in: Xenotransplantation may be here ‘within the next five years,’ but concerns loom
3 years ago
R&D
Immunic shares cut in half as biotech dumps ulcerative colitis after PhII fail
3 years ago
R&D
Boehringer Ingelheim inks deal for targeted cancer antibodies from Singapore research org
3 years ago
Deals
R&D
Despite a PhIII fail, Biogen pushes ALS drug tofersen forward with new analysis in move echoing Aduhelm
3 years ago
R&D
Amylyx's ALS drug gets a three-month PDUFA delay, setting up the pivotal decision for September
3 years ago
R&D
FDA+
Bristol Myers jumps into the M&A game with a $4B oncology buyout. And weary biotech analysts couldn't be any happier
3 years ago
Deals
Days after disclosing trial flop, stem cell therapy developer axes 70% of workforce while searching for cash
3 years ago
People
All in on early-stage, Qiming US bags $260M, recruits Atara founder Isaac Ciechanover for Fund III
3 years ago
Financing
Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO ...
3 years ago
Peer Review
Regeneron inks $1B+ deal for global rights to Sanofi-partnered PD-1 Libtayo
3 years ago
Deals
Pharma
Pfizer, like Moderna, fires back at Alnylam suit over Covid-19 vaccine patents
3 years ago
Pharma
Coronavirus
Novartis resumes remote business in Ukraine after safety protocol review
3 years ago
Pharma
Another refuse-to-file for a small biotech — is the FDA using RTFs to manage its workload?
3 years ago
FDA+
Organon debuts murals created by women around the world, plus ambitious ESG plan, on first anniversary
3 years ago
Pharma
Marketing
Gilead poaches new pharma development and manufacturing chief from cell therapy 2.0 player
3 years ago
R&D
Manufacturing
FDA compliance vet heads to India-based Lupin after long public career
3 years ago
People
FDA+
Manufacturing roundup: Lonza collaborates with a VC in Israel; Piramal updates one facility while opening a new one
3 years ago
Manufacturing
The target is the system: Condensates biotech aspires to ‘rewrite the rulebook’ on drug discovery
3 years ago
Financing
Biogen, Samsung Bioepis look to carve up a blockbuster Roche franchise with deep discount biosimilar
3 years ago
Marketing
First page
Previous page
511
512
513
514
515
516
517
Next page
Last page